What Farallon Capital Management LLC changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$21.7bn
$5.2bn at Q2 2013
Positions
89
82 at Q2 2013
Top ten weight
62%
42% at Q2 2013
Typical quarterly turnover
about 21%
Estimated from share changes
- Q2 2013: $5.2bn
- Q3 2013: $4.9bn
- Q4 2013: $4.8bn
- Q1 2014: $5.1bn
- Q2 2014: $6.9bn
- Q3 2014: $6.2bn
- Q4 2014: $7.3bn
- Q1 2015: $6.8bn
- Q2 2015: $7.4bn
- Q3 2015: $7.6bn
- Q4 2015: $11.2bn
- Q1 2016: $10.5bn
- Q2 2016: $7.3bn
- Q3 2016: $6.8bn
- Q4 2016: $8.7bn
- Q1 2017: $9.1bn
- Q2 2017: $9.6bn
- Q3 2017: $11.3bn
- Q4 2017: $12.3bn
- Q1 2018: $14.4bn
- Q2 2018: $16.2bn
- Q3 2018: $16.9bn
- Q4 2018: $13.6bn
- Q1 2019: $13.3bn
- Q2 2019: $15.4bn
- Q3 2019: $13.2bn
- Q4 2019: $14.8bn
- Q1 2020: $11.7bn
- Q2 2020: $12.5bn
- Q3 2020: $14.5bn
- Q4 2020: $16.6bn
- Q1 2021: $20.1bn
- Q2 2021: $24.5bn
- Q3 2021: $21.4bn
- Q4 2021: $20.0bn
- Q1 2022: $20.7bn
- Q2 2022: $18.4bn
- Q3 2022: $18.2bn
- Q4 2022: $16.9bn
- Q1 2023: $18.3bn
- Q2 2023: $19.9bn
- Q3 2023: $21.4bn
- Q4 2023: $21.9bn
- Q1 2024: $23.6bn
- Q2 2024: $23.3bn
- Q3 2024: $22.8bn
- Q4 2024: $22.8bn
- Q1 2025: $20.9bn
- Q2 2025: $23.8bn
- Q3 2025: $24.4bn
- Q4 2025: $23.1bn
- Q1 2026: $19.1bn
- Q2 2026: $21.7bn
- Q2 2013: 42%
- Q3 2013: 42%
- Q4 2013: 39%
- Q1 2014: 41%
- Q2 2014: 40%
- Q3 2014: 37%
- Q4 2014: 41%
- Q1 2015: 41%
- Q2 2015: 48%
- Q3 2015: 47%
- Q4 2015: 58%
- Q1 2016: 60%
- Q2 2016: 56%
- Q3 2016: 54%
- Q4 2016: 52%
- Q1 2017: 49%
- Q2 2017: 53%
- Q3 2017: 57%
- Q4 2017: 58%
- Q1 2018: 54%
- Q2 2018: 54%
- Q3 2018: 56%
- Q4 2018: 51%
- Q1 2019: 48%
- Q2 2019: 55%
- Q3 2019: 51%
- Q4 2019: 44%
- Q1 2020: 46%
- Q2 2020: 33%
- Q3 2020: 32%
- Q4 2020: 31%
- Q1 2021: 33%
- Q2 2021: 39%
- Q3 2021: 34%
- Q4 2021: 37%
- Q1 2022: 38%
- Q2 2022: 32%
- Q3 2022: 32%
- Q4 2022: 35%
- Q1 2023: 38%
- Q2 2023: 44%
- Q3 2023: 50%
- Q4 2023: 52%
- Q1 2024: 52%
- Q2 2024: 48%
- Q3 2024: 40%
- Q4 2024: 40%
- Q1 2025: 40%
- Q2 2025: 45%
- Q3 2025: 48%
- Q4 2025: 44%
- Q1 2026: 50%
- Q2 2026: 62%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Spdr S&P 500 Etf Trust(SPY) | Q3 2015 | $6.0bnQ1 2024 | $4.5bn | |
| Revolution Medicines Inc(RVMD) | Q1 2020 | $2.5bnQ2 2026 | $2.5bn | |
| Electronic Arts Inc(EA) | Q4 2025 | $1.6bnQ2 2026 | $1.6bn | |
| Bridgebio Pharma Inc(BBIO) | Q4 2023 | $800mQ2 2026 | $800m | |
| Protagonist Therapeutics Inc(PTGX) | Q4 2017 | $778mQ2 2026 | $778m | |
| Exelixis Inc(EXEL) | Q2 2016 | $832mQ1 2025 | $733m | |
| Liquidia Technologies Inc(LQDA) | Q1 2024 | $667mQ2 2026 | $667m | |
| Amazon Com Inc(AMZN) | Q2 2025 | $1.0bnQ4 2025 | $628m | |
| Lantheus HLDGS Inc(LNTH) | Q2 2020 | $619mQ2 2026 | $619m | |
| Natera Inc(NTRA) | Q2 2021 | $897mQ4 2025 | $602m | |
| Unitedhealth Group Inc(UNH) | Q1 2023 | $842mQ1 2024 | $528m | |
| Thermo Fisher Scientific Inc(TMO) | Q4 2019 | $723mQ1 2022 | $526m | |
| Spdr S&P 500 Etf Trust(SPY) | Q4 2024 | $3.4bnQ2 2025 | Soldlast listed Q2 2025 | |
| iShares IBOXX High Yield ETF(HYG) | Q2 2025 | $3.2bnQ3 2025 | Soldlast listed Q4 2025 | |
| Altaba Inc | Q2 2017 | $2.0bnQ1 2019 | Soldlast listed Q3 2019 | |
| Activision Blizzard Inc | Q1 2022 | $1.9bnQ3 2023 | Soldlast listed Q3 2023 | |
| Spdr S&P 500 Etf Trust(SPY) | Q3 2015 | $1.9bnQ4 2018 | Soldlast listed Q4 2021 | |
| Allergan PLC | Q2 2015 | $1.6bnQ1 2020 | Soldlast listed Q1 2020 | |
| Celgene Corp | Q1 2019 | $1.5bnQ3 2019 | Soldlast listed Q3 2019 | |
| Aetna Inc New | Q2 2015 | $1.5bnQ3 2018 | Soldlast listed Q3 2018 |
Quarter by quarter
Q4 2021: $20.0bn across 300 positions
Against Q3 2021: 45 new, 66 added to, 42 trimmed, 45 sold out, across all 300 positions.
Turnover about 13% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Howmet Aerospace Inc (HWM)+$201m
- Alphabet Inc (GOOG)+$182m
- Iqvia HLDGS Inc (IQV)+$179m
- Abbvie Inc (ABBV)+$166m
- CVS Health Corp (CVS)+$112m
- Boston Scientific Corp (BSX)+$107m
- Full Truck Alliance Co LTD (YMM)+$105m
- Transunion (TRU)+$103m
Largest reductions
- Spdr S&P 500 Etf Trust (SPY)-$370m
- Nuance Communications Inc-$325m
- Salesforce Com Inc (CRM)-$145m
- Amyris Inc-$102m
- Fate Therapeutics Inc (FATE)-$93m
- Spdr S&P 500 Etf Trust (SPY)-$92m
- Charter Communications Inc N (CHTR)-$71m
- Somalogic Inc-$51m
Opened
Nothing new among the largest positions.
Sold out
- T-mobile US Inc (TMUS)was $588m
- Acceleron Pharma Incwas $373m
- Willis Towers Watson PLC LTD (WTW)was $319m
- Kansas City Southernwas $319m
- Hilton Worldwide HLDGS Inc (HLT)was $275m
- Fidelity Natl Information SV (FIS)was $267m
- Macquarie Infrastr Hold LLCwas $177m
- Iqiyi Incwas $134m
Largest positions, Q4 2021
The largest 25 of 300 reported positions.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Spdr S&P 500 Etf Trust (SPY) | $1.5bn | 7.6% | Trimmed |
| Iqvia HLDGS Inc (IQV) | $827m | 4.1% | Added |
| Spdr S&P 500 Etf Trust (SPY) | $788m | 3.9% | Trimmed |
| Boston Scientific Corp (BSX) | $714m | 3.6% | Added |
| Alphabet Inc (GOOG) | $663m | 3.3% | Added |
| Aramark (ARMK) | $662m | 3.3% | Trimmed |
| Thermo Fisher Scientific Inc (TMO) | $649m | 3.2% | Trimmed |
| Wabtec Corp (WAB) | $575m | 2.9% | Added |
| Xilinx Inc | $561m | 2.8% | Trimmed |
| Howmet Aerospace Inc (HWM) | $526m | 2.6% | Added |
| Raytheon Technologies Corp (RTX) | $497m | 2.5% | Added |
| Facebook Inc (META) | $460m | 2.3% | Added |
| Microsoft Corp (MSFT) | $458m | 2.3% | Trimmed |
| BHP Group PLC | $406m | 2.0% | Added |
| New York Times Co (NYT) | $403m | 2.0% | Added |
| Mastercard Incorporated (MA) | $400m | 2.0% | Added |
| Aon PLC (AON) | $359m | 1.8% | Trimmed |
| Centene Corp Del (CNC) | $358m | 1.8% | Trimmed |
| Anthem Inc (ELV) | $350m | 1.7% | Trimmed |
| Sherwin Williams Co (SHW) | $335m | 1.7% | Trimmed |
| Transunion (TRU) | $331m | 1.7% | Added |
| Servicenow Inc (NOW) | $327m | 1.6% | Added |
| Broadcom Inc (AVGO) | $320m | 1.6% | Trimmed |
| Blackstone Group Inc (BX) | $310m | 1.5% | Trimmed |
| Visa Inc (V) | $307m | 1.5% | Added |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| Janus Henderson Group Ltd | at least 11% | 30 | Compare | |
| Maverick Capital Ltd | 11% | 9 | Compare | |
| Viking Global Investors LP | 11% | 8 | Compare | |
| Woodline Partners LP | at least 10% | 29 | Compare | |
| MFS Investment Management | at least 10% | 18 | Compare | |
| T. Rowe Price Associates Inc | at least 9.8% | 25 | Compare | |
| Arrowstreet Capital LP | at least 9.3% | 20 | Compare | |
| Dodge & Cox | 9.3% | 18 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Farallon Capital Management LLC | $21.7bn | 13F-HR | |
| Q1 2026 | Farallon Capital Management LLC | $19.1bn | 1 | 13F-HR |
| Q4 2025 | Farallon Capital Management LLC | $23.1bn | 2 | 13F-HR |
| Q3 2025 | Farallon Capital Management LLC | $24.4bn | 13F-HR | |
| Q2 2025 | Farallon Capital Management LLC | $23.8bn | 2 | 13F-HR |
| Q1 2025 | Farallon Capital Management LLC | $20.9bn | 3 | 13F-HR |
| Q4 2024 | Farallon Capital Management LLC | $22.8bn | 4 | 13F-HR |
| Q3 2024 | Farallon Capital Management LLC | $22.8bn | 4 | 13F-HR |
| Q2 2024 | Farallon Capital Management LLC | $23.3bn | 5 | 13F-HR |
| Q1 2024 | Farallon Capital Management LLC | $23.6bn | 4 | 13F-HR |
| Q4 2023 | Farallon Capital Management LLC | $21.9bn | 3 | 13F-HR |
| Q3 2023 | Farallon Capital Management LLC | $21.4bn | 4 | 13F-HR |
| Q2 2023 | Farallon Capital Management LLC | $19.9bn | 3 | 13F-HR |
| Q1 2023 | Farallon Capital Management LLC | $18.3bn | 3 | 13F-HR |
| Q4 2022 | Farallon Capital Management LLC | $16.9bn | 3 | 13F-HR |
| Q3 2022 | Farallon Capital Management LLC | $18.2bn | 4 | 13F-HR |
| Q2 2022 | Farallon Capital Management LLC | $18.4bn | 5 | 13F-HR |
| Q1 2022 | Farallon Capital Management LLC | $20.7bn | 5 | 13F-HR |
| Q4 2021 | Farallon Capital Management LLC | $20.0bn | 5 | 13F-HR |
| Q3 2021 | Farallon Capital Management LLC | $21.4bn | 5 | 13F-HR |
| Q2 2021 | Farallon Capital Management LLC | $24.5bn | 6 | 13F-HR |
| Q1 2021 | Farallon Capital Management LLC | $20.1bn | 6 | 13F-HR |
| Q4 2020 | Farallon Capital Management LLC | $16.6bn | 4 | 13F-HR |
| Q3 2020 | Farallon Capital Management LLC | $14.5bn | 2 | 13F-HR |
| Q2 2020 | Farallon Capital Management LLC | $12.5bn | 2 | 13F-HR |
| Q1 2020 | Farallon Capital Management LLC | $11.7bn | 2 | 13F-HR |
| Q4 2019 | Farallon Capital Management LLC | $14.8bn | 1 | 13F-HR |
| Q3 2019 | Farallon Capital Management LLC | $13.2bn | 2 | 13F-HR |
| Q2 2019 | Farallon Capital Management LLC | $15.4bn | 4 | 13F-HR |
| Q1 2019 | Farallon Capital Management LLC | $13.3bn | 3 | 13F-HR |
| Q4 2018 | Farallon Capital Management LLC | $13.6bn | 2 | 13F-HR |
| Q3 2018 | Farallon Capital Management LLC | $16.9bn | 13F-HR | |
| Q2 2018 | Farallon Capital Management LLC | $16.2bn | 13F-HR | |
| Q1 2018 | Farallon Capital Management LLC | $14.4bn | 13F-HR | |
| Q4 2017 | Farallon Capital Management LLC | $12.3bn | 13F-HR | |
| Q3 2017 | Farallon Capital Management LLC | $11.3bn | 13F-HR | |
| Q2 2017 | Farallon Capital Management LLC | $9.6bn | 13F-HR | |
| Q1 2017 | Farallon Capital Management LLC | $9.1bn | 13F-HR | |
| Q4 2016 | Farallon Capital Management LLC | $8.7bn | 13F-HR | |
| Q3 2016 | Farallon Capital Management LLC | $6.8bn | 13F-HR | |
| Q2 2016 | Farallon Capital Management LLC | $7.3bn | 13F-HR | |
| Q1 2016 | Farallon Capital Management LLC | $10.5bn | 13F-HR | |
| Q4 2015 | Farallon Capital Management LLC | $11.2bn | 13F-HR | |
| Q3 2015 | Farallon Capital Management LLC | $7.6bn | 13F-HR | |
| Q2 2015 | Farallon Capital Management LLC | $7.4bn | 13F-HR | |
| Q1 2015 | Farallon Capital Management LLC | $6.8bn | 13F-HR | |
| Q4 2014 | Farallon Capital Management LLC | $7.3bn | 13F-HR | |
| Q3 2014 | Farallon Capital Management LLC | $6.2bn | 13F-HR | |
| Q2 2014 | Farallon Capital Management LLC | $6.9bn | 13F-HR | |
| Q1 2014 | Farallon Capital Management LLC | $5.1bn | 13F-HR | |
| Q4 2013 | Farallon Capital Management LLC | $4.8bn | 13F-HR | |
| Q3 2013 | Farallon Capital Management LLC | $4.9bn | 13F-HR | |
| Q2 2013 | Farallon Capital Management LLC | $5.2bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More